Simon Xi PhD, BSc

Dr. Simon Xi has of computational biology and genomics research experience in both industry and academic settings. Dr Xi currently leads the Chemical Genomics and Integrative Biology (CGIB) function in Computational Sciences, with a mission to unlock the therapeutic potential of genomics research for drug discovery. Dr. Xi’s group also developed the experimental and computational platform for NextGen sequencing, and pioneered novel NGS approaches for a range of drug discovery applications in Pfizer (e.g. target discovery, chemical biology). Dr. Xi is also a PI in the GTEx consortium and active participant of several public-private consortia including Psychiatric Genomics Consortium, Brainseq consortium. Simon holds a BSc in Biochemistry from University of New South Wales, Australia, and a Ph.D. in Bioinformatics in Boston University.